Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phio Pharmaceuticals

2.96
+0.500020.33%
Post-market: 2.990.0300+1.01%19:52 EDT
Volume:2.07M
Turnover:6.11M
Market Cap:14.20M
PE:-0.31
High:3.19
Open:2.54
Low:2.53
Close:2.46
Loading ...
Mar 25, 2021

Major Issues Report

8-K - Current report
Mar 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 10, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2020

Major Issues Report

8-K - Current report
Aug 12, 2020

Major Issues Report

8-K - Current report
Aug 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 15, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 09, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 29, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 28, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 28, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933